NDC 73019-0200-1 - Asparaginase Lyophilized

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
73019-0200
Requested NDC
73019-0200-1
Package NDCs from labels
73019-0200-1, 73019-0200-2
Manufacturer
SAJJALA BIO LABS PRIVATE LIMITED
Effective date
2021-05-04
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Asparaginase Lyophilized - SAJJALA BIO LABS PRIVATE LIMITEDSAJJALA BIO LABS PRIVATE LIMITED2021-05-04BULK INGREDIENT

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73019-0200-1Asparaginase Lyophilized10000 [iU] in 1 VIALPOWDER100002
73019-0200-2Asparaginase Lyophilized50000 [iU] in 1 VIALPOWDER500002

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
73019-0200ASPARAGINASE LYOPHILIZED POWDER [SAJJALA BIO LABS PRIVATE LIMITED]22 package rows20210430_9e69aefe-cd91-4335-8f18-9f510266d77c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RylazeASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWNJazz Pharmaceuticals, Inc.857e53aa-1098-4dad-b654-0276cdd43e032025-07-01Warnings, Adverse reactionsExact identifier
unii: G4FQ3CKY5R

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.